NCT06395090 2025-04-08
MK-9999-01B
Merck Sharp & Dohme LLC
Phase 1/2 Withdrawn
Clinical Trials
4 trialsNCT02705703 2018-08-28
Consolidation Therapy in Patients With Metastatic Solid Malignancies
Kiromic BioPharma Inc.
Phase 1/2 Withdrawn
NCT00124956 2017-09-11
Doxorubicin Pharmacokinetic (PK) Study
Boston Children's Hospital
Phase 1/2 Withdrawn
NCT00166686 2013-01-11
Clonidine for Neurocognitive Sequelae
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 1/2 Withdrawn